Literature DB >> 16048354

Undesirable effects of citrus juice on the pharmacokinetics of drugs: focus on recent studies.

Mitsuo Saito1, Mutsuko Hirata-Koizumi, Mariko Matsumoto, Tsutomu Urano, Ryuichi Hasegawa.   

Abstract

It is well known that intake of grapefruit juice affects the pharmacokinetics of various kinds of drugs. It has been reported that other citrus juices also interact with certain drugs. To re-evaluate citrus juice-drug interactions based on currently available evidence, a literature search was conducted for new and updated information since the grapefruit juice-drug interaction was last reviewed in 1998. MEDLINE (1998-October 2004) was accessed and more than 200 reports were found. The effects of grapefruit juice ingestion on the pharmacokinetics of orally administered drugs have been reported for 40 drugs since the reviews published in 1998. Increases in either area under the concentration-time curve (AUC) or maximum plasma concentration (C(max)) were found with 34 of these, the major mechanism being considered to be inactivation of intestinal cytochrome P450 3A4, a so-called mechanism-based inhibition. Although recent reports point to the inhibitory effects of grapefruit juice on the function of P-glycoprotein, which transports substrates from enterocytes back into the lumen, the contribution to the bioavailability of drugs that are substrates of P-glycoprotein has not been established yet. Dramatic decreases in AUC and C(max) for two drugs in association with grapefruit juice ingestion has been reported and, in these cases, inhibitory effects on organic anion transporting polypeptide, which mediates absorption from the intestinal lumen to enterocytes, might be involved. Other citrus juices such as Seville (sour) orange juice and commonly ingested varieties of orange juice also showed significant effects on the AUC and C(max) of some drugs. Although the situation is complex and uncertainties remain, we recommend that patients avoid citrus juice intake while taking medications and that healthcare providers advise against citrus juice intake in this setting until any interactions with subject drugs can be clarified in clinical studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16048354     DOI: 10.2165/00002018-200528080-00003

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  116 in total

1.  Lack of significant pharmacokinetic interaction between haloperidol and grapefruit juice.

Authors:  N Yasui; T Kondo; A Suzuki; K Otani; K Mihara; H Furukori; S Kaneko; Y Inoue
Journal:  Int Clin Psychopharmacol       Date:  1999-03       Impact factor: 1.659

Review 2.  The flavonoids. A class of semi-essential food components: their role in human nutrition.

Authors:  J Kühnau
Journal:  World Rev Nutr Diet       Date:  1976       Impact factor: 0.575

3.  Phenols in citrus peel byproducts. Concentrations of hydroxycinnamates and polymethoxylated flavones in citrus peel molasses.

Authors:  J A Manthey; K Grohmann
Journal:  J Agric Food Chem       Date:  2001-07       Impact factor: 5.279

4.  Grapefruit juice can increase the plasma concentrations of oral methylprednisolone.

Authors:  T Varis; K T Kivistö; P J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  2000-09       Impact factor: 2.953

5.  Effects of grapefruit juice on the stereoselective disposition of nicardipine in humans: evidence for dominant presystemic elimination at the gut site.

Authors:  T Uno; T Ohkubo; K Sugawara; A Higashiyama; S Motomura; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  2000-12       Impact factor: 2.953

6.  Effect of grapefruit juice dose on grapefruit juice-triazolam interaction: repeated consumption prolongs triazolam half-life.

Authors:  J J Lilja; K T Kivistö; J T Backman; P J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  2000-08       Impact factor: 2.953

Review 7.  Interactions between grapefruit juice and cardiovascular drugs.

Authors:  David G Bailey; George K Dresser
Journal:  Am J Cardiovasc Drugs       Date:  2004       Impact factor: 3.571

8.  Orange juice substantially reduces the bioavailability of the beta-adrenergic-blocking agent celiprolol.

Authors:  Jari J Lilja; Laura Juntti-Patinen; Pertti J Neuvonen
Journal:  Clin Pharmacol Ther       Date:  2004-03       Impact factor: 6.875

9.  The fate of naringin in humans: a key to grapefruit juice-drug interactions?

Authors:  U Fuhr; A L Kummert
Journal:  Clin Pharmacol Ther       Date:  1995-10       Impact factor: 6.875

Review 10.  Citrus fruits--varieties, chemistry, technology, and quality evaluation. Part II. Chemistry, technology, and quality evaluation. A. Chemistry.

Authors:  S Ranganna; V S Govindarajan; K V Ramana
Journal:  Crit Rev Food Sci Nutr       Date:  1983       Impact factor: 11.176

View more
  17 in total

Review 1.  Influence of dietary substances on intestinal drug metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Curr Drug Metab       Date:  2010-11       Impact factor: 3.731

Review 2.  Fruit juice inhibition of uptake transport: a new type of food-drug interaction.

Authors:  David G Bailey
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

Review 3.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  Potential of pharmacokinetic profiling for detecting herbal interactions with drugs.

Authors:  Veronika Butterweck; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 5.  Interaction of Citrus Juices with Cyclosporine: Systematic Review and Meta-Analysis.

Authors:  Kannan Sridharan; Gowri Sivaramakrishnan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

6.  Suspected adverse reactions associated with herbal products used for weight loss: a case series reported to the Italian National Institute of Health.

Authors:  Annabella Vitalone; Francesca Menniti-Ippolito; Paola Angela Moro; Fabio Firenzuoli; Roberto Raschetti; Gabriela Mazzanti
Journal:  Eur J Clin Pharmacol       Date:  2011-01-18       Impact factor: 2.953

7.  Grapefruit juice improves glucose intolerance in streptozotocin-induced diabetes by suppressing hepatic gluconeogenesis.

Authors:  Julia A Hayanga; Senelisiwe P Ngubane; Alfred N Murunga; Peter M O Owira
Journal:  Eur J Nutr       Date:  2015-03-20       Impact factor: 5.614

8.  Serum concentrations and clinical effects of atorvastatin in patients taking grapefruit juice daily.

Authors:  Patrick Reddy; David Ellington; Yiliang Zhu; Immo Zdrojewski; Sarah J Parent; Jerold S Harmatz; Hartmut Derendorf; David J Greenblatt; Kevin Browne
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

Review 9.  Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Pharmacol Ther       Date:  2012-08-04       Impact factor: 12.310

10.  Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women.

Authors:  Monica Gandhi; Leslie Z Benet; Peter Bacchetti; Ann Kalinowski; Kathryn Anastos; Alan R Wolfe; Mary Young; Mardge Cohen; Howard Minkoff; Stephen J Gange; Ruth M Greenblatt
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-15       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.